Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Lenalidomide in Advanced RCC
NCT00403169Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Aug 2004
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in renal cell carcinoma (RCC), sponsored by Cleveland Clinic. Started Aug 2004; status: completed.
02
Drugs
lenalidomide
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00403169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403169.